GALECTIN THERAPEUTICS INC. Interest Expense, Related Party
GALECTIN THERAPEUTICS INC. (GALT) reported Interest Expense, Related Party of $39.00 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseRelatedParty · last filed 2022-11-14
- GALECTIN THERAPEUTICS INC. interest expense, related party for the quarter ending 2021-12-31 was $109.00K, a 395.45% increase year-over-year.
- GALECTIN THERAPEUTICS INC. interest expense, related party for the quarter ending 2020-12-31 was $22.00K.
- GALECTIN THERAPEUTICS INC. interest expense, related party for fiscal 2021 was $174.00K, a 100.00% increase from fiscal 2020.
- GALECTIN THERAPEUTICS INC. interest expense, related party for fiscal 2020 was $87.00K.
| Period end | Interest Expense, Related Party 3 month | Interest Expense, Related Party 9 month | Interest Expense, Related Party 12 month |
|---|---|---|---|
| 2022-09-30 | $39.00K 10-Q · filed 2022-11-14 | ||
| 2021-12-31 | $109.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $174.00K 10-K · filed 2022-03-31 | |
| 2021-09-30 | $65.00K 10-Q · filed 2021-11-15 | ||
| 2020-12-31 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $87.00K 10-K · filed 2022-03-31 | |
| 2020-09-30 | $65.00K 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |